Janet Rowley | Academic Influence

Janet Rowley's AcademicInfluence.com Rankings

Janet Rowley

Biology

#630

World Rank

#1110

Historical Rank

#353

USA Rank

Genetics

#72

World Rank

#105

Historical Rank

#48

USA Rank

biology Degrees

Download Badge

Biology

Janet Rowley's Degrees

Masters Medicine University of Chicago

Why Is Janet Rowley Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Janet Davison Rowley was an American human geneticist and the first scientist to identify a chromosomal translocation as the cause of leukemia and other cancers, thus proving that cancer is a genetic disease. Rowley spent the majority of her life working in Chicago and received many awards and honors throughout her life, recognizing her achievements and contributions in the area of genetics.

(See a Problem?)

Janet Rowley's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining (1973) (4159)
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. (1995) (787)
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. (2003) (650)
15/17 TRANSLOCATION, A CONSISTENT CHROMOSOMAL CHANGE IN ACUTE PROMYELOCYTIC LEUKAEMIA (1977) (625)
Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. (1991) (606)
The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP96 and class I homeoprotein HOXA9 (1996) (469)
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations (2008) (458)
Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. (1981) (444)
Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. (1984) (423)
Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. (2000) (402)
The critical role of chromosome translocations in human leukemias. (1998) (402)
Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. (1988) (393)
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia (2007) (371)
Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia (1996) (366)
Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping (1997) (358)
AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. (1995) (349)
MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). (1997) (338)
Chromosomal banding patterns in acute nonlymphocytic leukemia. (1976) (334)
Over 20% of human transcripts might form sense-antisense pairs. (2004) (326)
The Chromosomes in Human Cancer and Leukemia (1981) (325)
Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. (1993) (306)
The role of chromosome translocations in leukemogenesis. (1999) (294)
The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. (1996) (294)
A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis (2006) (284)
Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. (1979) (281)
Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. (1984) (281)
Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. (1994) (277)
Chromosome translocations: dangerous liaisons revisited (2001) (275)
Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc-binding finger" structure. (1988) (272)
The t(8;21) fusion protein, AML1–ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia (2002) (267)
Onco gen: Human oncogene locations and chromosome aberrations (1983) (266)
Identification of the constant chromosome regions involved in human hematologic malignant disease. (1982) (264)
The human met oncogene is related to the tyrosine kinase oncogenes (1985) (261)
Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells (1987) (258)
11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene. (1994) (258)
Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome. (1990) (243)
Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA- topoisomerase II (1993) (235)
All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. (1997) (232)
Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. (2009) (229)
Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. (1995) (225)
Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. (1994) (224)
Mapping of human chromosomal regions related to neoplasia: evidence from chromosomes 1 and 17. (1977) (220)
Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders. (1986) (214)
Leukaemogenesis: more than mutant genes (2010) (206)
Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. (1992) (203)
Recurring chromosome abnormalities in leukemia and lymphoma. (1990) (199)
Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes (1986) (198)
Time-Sequence of Human Chromosome Duplication (1962) (194)
International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy‐related myelodysplastic syndromes and acute leukemia: Overview report (2002) (194)
Cancer biology: Heritable fragile sites in cancer (1984) (192)
Chromatin structural elements and chromosomal translocations in leukemia. (2006) (189)
MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). (1999) (184)
A method for the rapid sequence-independent amplification of microdissected chromosomal material. (1992) (183)
The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. (1993) (182)
"Microgranular" acute promyelocytic leukemia: a distinct clinical, ultrastructural, and cytogenetic entity. (1980) (181)
Nonrandom chromosomal abnormalities in acute nonlymphocytic leukemia in patients treated for Hodgkin disease and non-Hodgkin lymphomas (1977) (179)
TET1 plays an essential oncogenic role in MLL-rearranged leukemia (2013) (175)
Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. (1992) (173)
Oligo(dT) primer generates a high frequency of truncated cDNAs through internal poly(A) priming during reverse transcription (2002) (172)
Chromosome abnormalities in malignant hematologic diseases. (1982) (171)
Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. (2012) (168)
Correlation of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia: an eight-year study (1970-1977). (1978) (165)
Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia (1985) (161)
Identifying novel transcripts and novel genes in the human genome by using novel SAGE tags (2002) (160)
Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. (1993) (159)
Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes. (1992) (158)
Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. (1985) (158)
Associations between morphology, karyotype, and clinical features in myeloid leukemias. (1987) (158)
Chromosome 14 translocations in non‐burkitt lymphomas (1978) (155)
Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. (1989) (151)
Further evidence for a non‐random chromosomal abnormality in acute promyelocytic leukemia (1977) (151)
The Fourth International Workshop on Chromosomes in Leukemia: a prospective study of acute nonlymphocytic leukemia. Chicago, Illinois, U.S.A., September 2-7, 1982. (1984) (148)
Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. (1996) (148)
Chromosomal translocations: revisited yet again. (2008) (148)
Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia (2010) (145)
Genome-wide analysis of coordinate expression and evolution of human cis-encoded sense-antisense transcripts. (2005) (143)
An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. (1998) (143)
Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). (1989) (143)
Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders. (1987) (142)
Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. (2013) (141)
The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q. (1987) (136)
Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. (1993) (135)
Nonrandom chromosomal abnormalities in hematologic disorders of man. (1975) (135)
Chromosome studies in preleukemia. I. Aneuploidy of group C chromosomes in three patients. (1966) (131)
Leukaemogenesis: more than mutant genes (2010) (131)
Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Third International Workshop on Chromosomes in Leukemia. (1983) (130)
Cytogenetic studies on patients with chronic T cell leukemia/lymphoma. (1984) (127)
BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B‐cell malignancies: A molecular and cytogenetic study (1997) (123)
Detection of Fusion Transcripts Generated by the Inversion 16 Chromosome in Acute Myelogenous Leukemia (1994) (122)
Evolution of karyotypes in acute nonlymphocytic leukemia. (1979) (121)
Generation of longer cDNA fragments from serial analysis of gene expression tags for gene identification. (2000) (121)
PBX3 is an important cofactor of HOXA9 in leukemogenesis. (2013) (119)
miR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia (2012) (117)
Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11) (1990) (116)
Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia (1982) (116)
t(3;21)(q26;q22): A Recurring Chromosomal Abnormality in Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia (1990) (116)
A collaborative study of the relationship of the morphological type of acute nonlymphocytic leukemia with patient age and karyotype. (1982) (115)
Molecular cytogenetics: Rosetta stone for understanding cancer--twenty-ninth G. H. A. Clowes memorial award lecture. (1990) (115)
Cloning of the chromosome translocation breakpoint junction of the t(14;19) in chronic lymphocytic leukemia. (1987) (114)
Long‐term survival of patients with acute myeloid leukemia (1997) (111)
Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations. (1992) (111)
Evidence for two distinct c-src loci on human chromosomes 1 and 20 (1984) (110)
Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia (2002) (110)
MicroRNA Expression Signatures Accurately Discriminate Acute Lymphoblastic Leukemia from Acute Myeloid Leukemia. (2007) (109)
Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases. (1994) (108)
TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. (1995) (108)
Clinical-cytogenetic correlations in myelodysplasia (preleukemia). (1989) (108)
The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12-year study (1970-1982). (1983) (108)
Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. (1992) (108)
Philadelphia chromosome‐negative chronic myelogenous leukaemia: a morphological reassessment (1985) (107)
Gene encoding the alpha chain of the T-cell receptor is moved immediately downstream of c-myc in a chromosomal 8;14 translocation in a cell line from a human T-cell leukemia. (1986) (107)
Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL (1985) (107)
Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation. (1988) (103)
Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia. (1973) (103)
Chromosome pattern in childhood acute nonlymphocytic leukemia (ANLL) (1982) (101)
Karyotypic abnormalities and clinical aspects of patients with multiple myeloma and related paraproteinemic disorders (1979) (99)
The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin. (2004) (99)
miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia–rearranged leukemia (2013) (99)
Chromosome abnormalities in cancer (1980) (97)
Metallothionein gene cluster is split by chromosome 16 rearrangements in myelomonocytic leukaemia (1985) (97)
Abnormalities of chromosome 1 in myeloproliferative disorders (1975) (95)
Acute nonlymphocytic leukemia in adults: correlations with Q-banded chromosomes. (1976) (94)
Human oncogene locations and chromosome aberrations. (1983) (94)
The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis (1985) (93)
Interferon and c-ets-1 genes in the translocation (9;11)(p22;q23) in human acute monocytic leukemia. (1986) (93)
DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. (2000) (92)
CBFA2(AML1) Translocations With Novel Partner Chromosomes in Myeloid Leukemias: Association With Prior Therapy (1998) (92)
Editorial: Do human tumors show a chromosome pattern specific for each etiologic agent? (1974) (91)
Mimicry of a constitutively active pre–B cell receptor in acute lymphoblastic leukemia cells (2005) (89)
Chromosome abnormalities in B cell chronic lymphocytic leukemia and their clinical correlations. (1989) (87)
Dysmyelopoietic syndrome: sequential clinical and cytogenetic studies. (1980) (87)
The pattern of gene expression in human CD34+ stem/progenitor cells (2001) (87)
LAPTM5: a novel lysosomal-associated multispanning membrane protein preferentially expressed in hematopoietic cells. (1996) (85)
Partial deletion of long arm of chromosome 17: a specific abnormality in acute promyelocytic leukemia? (1976) (85)
Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia. (1987) (85)
Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion (1993) (84)
Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). (1994) (84)
Prognostic implications of karyotype and morphology in patients with non‐Hodgkin's lymphoma (1983) (83)
Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia. (1992) (82)
Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter. (1997) (81)
Molecular cloning of the breakpoint junction of a human chromosomal 8;14 translocation involving the T-cell receptor alpha-chain gene and sequences on the 3' side of MYC. (1986) (81)
Chromosome studies in non-Hodgkin's lymphomas. (1980) (79)
Chromosome abnormalities in human leukemia. (1980) (79)
Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignancies identified with fluorescence in situ hybridization. (1993) (79)
Isolation of a yeast artificial chromosome spanning the 8;21 translocation breakpoint t(8;21)(q22;q22.3) in acute myelogenous leukemia. (1991) (77)
TRITIATED THYMIDINE INCORPORATION IN AN ISOCHROMOSOME FOR THE LONG ARM OF THE X CHROMOSOME IN MAN (1963) (77)
Clonal, nonconstitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23. (1994) (75)
Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis (2013) (75)
Banding studies of chromosomal abnormalities in patients with acute lymphocytic leukemia. (1979) (72)
Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia. (1989) (72)
Information Marketing (2006) (72)
Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping (2001) (72)
Acute myelogenous leukemia and thrombocythemia associated with an abnormality of chromosome No. 3 (1979) (71)
The Philadelphia chromosome translocation a paradigm for understanding leukemia (1990) (71)
The der(II) chromosome contains the critical breakpoint junction in the 4;11, 9;11, and 11;19 translocations in acute leukemia (1992) (70)
Spectral karyotype analysis of T-cell acute leukemia. (1999) (70)
Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias. (2009) (70)
A 14;19 TRANSLOCATION IN B‐CELL CHRONIC LYMPHOCYTIC LEUKEMIA: A NEW RECURRING CHROMOSOME ABERRATION (1985) (69)
Rearrangements involving chromosome band 11Q23 in acute leukaemia. (1993) (67)
Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders. (1992) (65)
Cloning of the cDNA for a hematopoietic cell-specific protein related to CD20 and the beta subunit of the high-affinity IgE receptor: evidence for a family of proteins with four membrane-spanning regions. (1994) (65)
Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia. (1989) (64)
Sequence-independent amplification and labeling of yeast artificial chromosomes for fluorescence in situ hybridization. (1994) (64)
Human antisense genes have unusually short introns: evidence for selection for rapid transcription. (2005) (64)
Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells. (2005) (63)
Acute nonlymphocytic leukemia in malignant lymphoma. A morphologic study (1978) (62)
Cytogenetic and molecular analysis of the acute monocytic leukemia cell line THP‐1 with an MLL‐AF9 translocation (2000) (62)
Heritable fragile sites in cancer. (1984) (62)
Clinical implications of monosomy 7 in acute nonlymphocytic leukemia (1980) (62)
CHROMOSOME CHANGES IN ACUTE LEUKAEMIA (1980) (61)
Local gene density predicts the spatial position of genetic loci in the interphase nucleus. (2005) (61)
A t(6;12)(q23;p13) results in the fusion of ETV6 to a novel gene, STL, in a B‐cell ALL cell line (1997) (60)
Correlation between the ETV6/CBFA2 (TEL/AMLI) fusion gene and karyotypic abnormalities in children with B‐cell precursor acute lymphoblastic leukemia (1996) (60)
c-src is consistently conserved in the chromosomal deletion (20q) observed in myeloid disorders. (1985) (60)
Hypergranular promyelocytic leukemia (APL): cytogenetic and ultrastructural specificity. (1978) (60)
Chromosomal abnormalities in leukemia and lymphoma: clinical and biological significance. (1986) (59)
Silencing of B Cell Receptor Signals in Human Naive B Cells (2002) (59)
Association of red cell spherocytosis with deletion of the short arm of chromosome 8. (1987) (58)
Abnormalities of Chromosome Band 11q23 and the MLL Gene in Pediatric Myelomonocytic and Monoblastic Leukemias: Identification of the t(9;11) as an Indicator of Long Survival (1995) (57)
Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. (1986) (57)
Karyotypic patterns and their clinical significance in polycythemia vera (1981) (57)
Clonal, nonconstitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23 (1994) (56)
Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. (1982) (56)
Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. (1994) (54)
Heterogeneity in the breakpoints in balanced rearrangements involving band 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL (ETV6 ) is involved in only one half. (1997) (53)
Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. (1997) (53)
Comparable complex rearrangements involving 8;21 and 9;22 translocations in leukaemia (1977) (53)
Lymphoblastic lymphoma in adults (1981) (52)
Lymphoblastic lymphoma: Cytogenetic, pathologic, and immunologic studies (1982) (51)
Chromosome abnormalities in Down's syndrome patients with acute leukemia (1981) (51)
Chromosome abnormalities in patients with hairy cell leukemia (1978) (51)
Isolation and analysis of the 21q+ chromosome in the acute myelogenous leukemia 8;21 translocation: evidence that c-mos is not translocated. (1985) (51)
The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties. (1996) (50)
Detection of 11q23/MLL rearrangements in infant leukemias with fluorescence in situ hybridization and molecular analysis. (1995) (50)
Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia. (1985) (49)
Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy (1982) (49)
Translocation of the p53 gene in t(15;17) in acute promyelocytic leukaemia (1985) (49)
Analysis of deletions of the long arm of chromosome 11 in hematologic malignancies with fluorescence in situ hybridization (1993) (49)
Abnormalities of chromosome No. 1: Significance in malignant transformation (1978) (49)
Chromosomal aneuploidy in a patient with hypereosinophilic syndrome. Evidence for a malignant disease. (1977) (48)
Unique balanced chromosome abnormalities in treatment‐related myelodysplastic syndromes and acute myeloid leukemia: Report from an International Workshop † (2002) (48)
Molecular portraits of B cell lineage commitment (2002) (47)
Knockdown of Pu.1 by small interfering RNA in CD34+ embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells. (2005) (46)
Assignment of the GM-CSF, CSF-1, and FMS genes to human chromosome 5 provides evidence for linkage of a family of genes regulating hematopoiesis and for their involvement in the deletion (5q) in myeloid disorders. (1986) (45)
Chromosomes in Acute Promyelocytic Leukemia (1984) (45)
Identification of cytogenetically undetected 12p13 translocations and associated deletions with fluorescence in situ hybridization (1995) (45)
Synthesis of Deoxyribonucleic Acid on X-Chromosomes of an XXXXY Male (1963) (43)
Do terminal deletions of 11q23 exist? Identification of undetected translocations with fluorescence in situ hybridization (1993) (43)
The role of the c-mos gene in the 8;21 translocation in human acute myeloblastic leukemia. (1985) (43)
CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy. (1998) (42)
Gene expression profiles in acute myeloid leukemia with common translocations using SAGE. (2006) (42)
Chromosome identification—Technique and applications in biology and medicine. (1974) (42)
Relationship of Centromeric Heterochromatin to Fluorescent Banding Patterns of Metaphase Chromosomes in the Mouse (1971) (42)
Chromosomes and causation of human cancer and leukemia XXXV. The missing Y in acute non‐lymphocytic leukemia (ANLL) (1980) (42)
The AML1 and ETO genes in acute myeloid leukemia with a t(8;21). (1994) (42)
Chromosomal localization of the human T cell receptor β-chain genes (1985) (41)
The 14q+ chromosome in pre-B-ALL (1980) (41)
Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML‐2 cell line (1996) (39)
The LCK Gene Is Involved in the t(1;7)(p34;q34) in the T‐Cell Acute Lymphoblastic Leukemia Derived Cell Line, HSB‐2 (1991) (39)
14q+ MARKER CHROMOSOMES IN MULTIPLE MYELOMA AND PLASMA-CELL LEUKÆMIA (1978) (39)
Identification of complex genomic breakpoint junctions in the t(9;11) MLL‐AF9 fusion gene in acute leukemia (1997) (39)
Analysis of translocations that involve the NUP98 gene in patients with 11p15 chromosomal rearrangements (2004) (39)
T lymphoid differentiation in human bone marrow (2003) (38)
B cell acute lymphoblastic leukemia (ALL) with a 14q+ chromosome abnormality. (1979) (38)
Backtracking leukemia to birth (1998) (38)
PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22) (2004) (38)
Myeloid leukemia after hematotoxins. (1996) (38)
Association of specific chromosome abnormalities with type of acute leukemia and with patient age. (1981) (37)
Quantification by DNA-based cytophotometry of the 9q+/22q-chromosomal translocation associated with chronic myelogenous leukemia. (1977) (37)
Philadelphia Chromosome Symposium: commemoration of the 50th anniversary of the discovery of the Ph chromosome. (2011) (37)
The pattern of gene expression in human CD15+ myeloid progenitor cells (2001) (37)
Screening poly(dA/dT)- cDNAs for gene identification. (2000) (37)
Morphologic and cytochemical observations on the overt leukemic phase of therapy-related leukemia. (1983) (36)
Duplexes of 21‐nucleotide RNAs mediate RNA interference in differentiated mouse ES cells (2003) (35)
Chromosome abnormalities in leukemia. (1988) (35)
Banding studies of chromosomes in a patient with mycosis fungoides (1978) (35)
New Fusion Transcripts Identified in Normal Karyotype Acute Myeloid Leukemia (2012) (34)
Deletion of the long arm of chromosome 20 [del(20)(q11)] in myeloid disorders (1978) (34)
Molecular analysis of TCRB and ABL in a t(7;9)-containing cell line (SUP-T3) from a human T-cell leukemia. (1987) (34)
Acute monocytic leukemia. Cytologic, histologic, cytochemical, ultrastructural, and cytogenetic observations. (1976) (34)
The Cart Before the Horse (2008) (33)
Correct identification of genes from serial analysis of gene expression tag sequences. (2002) (33)
Hyperdiploidy arising from near‐haploidy in childhood acute lymphoblastic leukemia (1992) (33)
Chromosomal localization of the human G-CSF gene to 17q11 proximal to the breakpoint of the t(15;17) in acute promyelocytic leukemia. (1987) (32)
Consistent chromosome abnormalities in human leukemia and lymphoma. (1983) (32)
Chronic myelodysplastic syndrome (preleukemia) with the Philadelphia chromosome. (1980) (32)
A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome (2002) (32)
Cytogenetic and ultrastructural features of de novo acute promyelocytic leukemia; The university of Chicago experience (1973–1978)☆ (1979) (32)
Chromosomal localization and characterization of c-abl in the t(6;9) of acute nonlymphocytic leukemia. (1985) (32)
Chromosome abnormalities in acute lymphoblastic leukemia (1980) (32)
Hairy cell leukemia: An analysis of the chromosomes of 26 patients (1978) (31)
Loss of the Y Chromosome in Myelodysplasia: A Report of Three Cases Studied with Quinacrine Fluorescence (1971) (31)
Localization of the oncogene c‐erbA1 immediately proximal to the acute promyelocytic leukaemia breakpoint on chromosome 17 (1985) (31)
Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16) (2004) (30)
The mixed lineage leukemia (MLL) protein involved in 11q23 translocations contains a domain that binds cruciform DNA and scaffold attachment region (SAR) DNA. (1996) (30)
Evolution of karyotypes in philadelphia (Ph1) chromosome‐negative chronic myelogenous leukemia (1979) (29)
Chromosomal patterns in myelocytic leukemia. (1973) (29)
Chromosomes and Cancer: From Molecules to Man (1983) (29)
ABNORMALITIES OF CHROMOSOME NO. 1 IN HÆMATOLOGICAL MALIGNANCIES (1978) (29)
TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines (1996) (28)
Cancer genetics, cytogenetics—defining the enemy within (1998) (28)
The human MLL gene: nucleotide sequence, homology to the Drosophila trx zinc-finger domain, and alternative splicing. (1995) (28)
The transcriptome of human CD34+ hematopoietic stem-progenitor cells (2009) (28)
A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene MPFYVE on chromosome 15 (2003) (28)
Banding studies on chromosomes in diffuse histiocytic lymphomas: correlation of 14q+ marker chromosome with cytology (1978) (27)
Scaffold-associated regions in the human type I interferon gene cluster on the short arm of chromosome 9. (1998) (27)
Chromosomal banding patterns in patients with acute nonlymphocytic leukemia (1980) (27)
The molecular biology of myeloproliferative disorders as revealed by chromosomal abnormalities. (1995) (27)
Chromosome abnormalities in the acute phase of CML (1978) (27)
Cytogenetic studies in patients with hairy cell leukemia (2007) (27)
Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations. (2002) (26)
Cytogenetic studies of 21 patients with acute lymphoblastic leukemia in relapse. (1989) (26)
Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties. (1996) (26)
Variability of 11q23 rearrangements in hematopoietic cell lines identified with fluorescence in situ hybridization. (1993) (26)
Chromosome translocations: Dangerous liaisons (1998) (25)
Acute leukemia after treatment of lymphoma. (1977) (25)
Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies. (1999) (25)
Chromosomal Translocations and Genome Rearrangements in Cancer (2015) (24)
Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16). (2007) (24)
Cytogenetic and Molecular Analysis of Therapy‐Related Leukemia a (1989) (23)
Ph1-positive leukaemia, including chronic myelogenous leukaemia. (1980) (23)
Hu-ets-2 is translocated to chromosome 8 in the t(8;21) in acute myelogenous leukemia. (1986) (22)
Trisomy 8 in human hematologic neoplasia and the c-myc and c-mos oncogenes. (1985) (22)
Chronic myeloid leukemia: current perspectives. (2011) (22)
The clinical applications of new DNA diagnostic technology on the management of cancer patients. (1993) (21)
Differential expression of TCL1 during pre-B-cell acute lymphoblastic leukemia progression. (2002) (21)
MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemia (1999) (21)
The Philadelphia chromosome translocation. A paradigm for understanding leukemia. (1990) (21)
Cytogenetic analysis in leukemia and lymphoma: an introduction. (2000) (20)
Idiopathic acquired refractory sideroblastic anemia: Banded chromosome analysis in six patients. (1977) (20)
Human T-cell lymphoma with suppressor effects on the mixed lymphocyte reaction (MLR). I. Morphological and cytogenetic analysis (1981) (20)
Chromosomes in Hodgkin's disease. (1982) (20)
The Small Introns of Antisense Genes Are Better Explained by Selection for Rapid Transcription Than by “Genomic Design” (2005) (19)
Deletion of the long arm of chromosome 20 [del(20)(q11)] in myeloid disorders. (1978) (19)
Possible non random selection of D group chromosomes involved in centric-fusion translocations. (1969) (19)
Scaffold attachment regions in centromere-associated DNA (1996) (18)
Evidence favoring lineage fidelity in acute nonlymphocytic leukemia: absence of immunoglobulin gene rearrangements in FAB types M4 and M5 (1987) (18)
T-cell receptor alpha-chain gene is split in a human T-cell leukemia cell line with a t(11;14)(p15;q11). (1986) (18)
Significance of cytogenetic abnormalities in acute leukemias. (1981) (18)
2 – Identification of Human Chromosomes (1974) (18)
Molecular analysis of the t(8;14)(q24;q11) chromosomal breakpoint junctions in the T‐cell leukemia line MOLT‐16 (1997) (17)
DNA rearrangements and altered transcripts of the MLL gene in a human T‐all cell line karpas 45 with a t(X;II) (q13;q23) translocation (1994) (17)
Chromosomes in leukemia and beyond: from irrelevant to central players. (2009) (17)
Methods of processing marrow samples may affect the frequency of detectable aneuploid cells (1981) (17)
Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B study. (1994) (16)
Methods for the analysis of human chromosome aberrations (1974) (16)
Letter: Another variant translocation in chronic myelogenous leukemia--revisited. (1976) (16)
A Story of Swapped Ends (2013) (16)
An (8;14)(q24;q11) translocation involving the T‐cell receptor α‐chain gene and the MYC oncogene 3′ region in a B‐cell lymphoma (1989) (16)
Response to 5‐azacytidine in patients with refractory acute nonlymphocytic leukemia and association with chromosome findings (1982) (15)
Harmful Moratorium on Stem Cell Research (2002) (15)
A strategy for genome-wide gene analysis: integrated procedure for gene identification. (1998) (15)
Do all leukemic cells have an abnormal karyotype? (1981) (15)
DNA cytophotometry of chromosomes in a case of chronic myelogenous leukemia. (1974) (15)
The AML1 gene in the 8;21 and 3;21 translocations in chronic and acute myeloid leukemia. (1994) (15)
Identification of a 1.2 Kb cDNA fragment from a region on 9p21 commonly deleted in multiple tumor types. (2001) (14)
Chromosome abnormalities in leukemia. (1988) (14)
Evidence favoring lineage fidelity in acute nonlymphocytic leukemia: absence of immunoglobulin gene rearrangements in FAB types M4 and M5. (1987) (14)
A t(6;12)(q23;p13) results in the fusion of ETV6 to a novel gene, STL, in a B-cell ALL cell line. (1997) (14)
t(1;3)(p36;p21) is a recurring therapy‐related translocation (2002) (14)
Polymorphisms in the MLL breakpoint cluster region (BCR) (2003) (14)
Chromosome abnormalities in leukemia and lymphoma. (1983) (14)
Chromosomal translocations in secondary acute myeloid leukemia. (1996) (14)
Variant translocations (9;11): identification of the critical genetic rearrangement. (1988) (14)
Absence of the 9q+chromosome in Ph1 negative chronic myelogenous leukaemia (1974) (13)
Screening and quantification of multiple chromosome translocations in human leukemia. (2003) (13)
A complex genetic rearrangement in a t(10;14)(q24;q11) associated with T‐cell acute lymphoblastic leukemia (1992) (13)
Two isoforms of HOXA9 function differently but work synergistically in human MLL-rearranged leukemia. (2012) (13)
A cytogenetic study of children in India with acute lymphocytic leukemia: correlation with clinical data. (1986) (12)
Nonrandom chromosomal changes in human malignant cells (1977) (12)
Chromosomes in human cancer. (1976) (12)
Establishment, characterization and differentiation induction of a new human diploid myelomonocytic cell line (HL-92) derived from a patient with acute myelomonocytic leukemia. (1982) (12)
Reuse of chromosome preparations for fluorescent staining. (1971) (12)
The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5 q ( gene mapping / hematopoietic growth factors / chromosomal deletions / malignant transformation ) (12)
1993 American Society of Human Genetics presidential address: can we meet the challenge? (1994) (11)
Molecular cytogenetic characterization of breakpoints in 19 patients with hematologic malignancies and 12p unbalanced translocations. (2003) (11)
Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysis. (1999) (11)
Correlation of in vitro culture pattern and Q‐banded karyotype in acute nonlymphocytic leukemia (1983) (11)
Chromosomes in leukemia and lymphoma. (1978) (11)
Seminars from the University of Minnesota. Chromosome translocations: dangerous liaisons. (1998) (10)
Chromosome pattern in childhood acute nonlymphocytic leukemia (ANLL). (1982) (10)
Constitutional chromosome abnormalities in patients with acute nonlymphocytic leukemia (1984) (10)
The leukemic phase of histiocytic lymphoma. Histologic, cytologic, cytochemical, ultrastructural, immunologic and cytogenetic observations in a case. (1978) (10)
Human T-cell lymphoma with suppressor effects on the mixed lymphocyte reaction (MLR). I. Morphological and cytogenetic analysis. (1981) (10)
Comparative gene mapping in cattle, Indian muntjac, and Chinese muntjac by fluorescence in situ hybridization (2008) (10)
Computer oriented analysis of human chromosomes. V. A case of chronic myelogenous leukemia (1974) (10)
PBX 3 is an important cofactor of HOXA 9 in leukemogenesis * (2013) (10)
Cytogenetic characterization of B-cell lymphomas from severe combined immunodeficiency disease mice given injections of lymphocytes from Epstein-Barr virus-positive donors. (1992) (10)
Chromosomal sublocalization of the human p97 melanoma antigen (1986) (9)
Cytogenetic patterns in acute nonlymphocytic leukemia (1978) (9)
General report on the second international workshop on chromosomes in leukemia (1980) (9)
U937 cell line has a t(I0;II)(pI3–I4;qI4–2I) rather than a deletion of IIq (1995) (8)
U937 cell line has a t(10;11)(p13-14;q14-21) rather than a deletion of 11q. (1995) (8)
Planning the Genome Institute's Future (2003) (8)
A chromosome marker for B-cell cancer. (1978) (8)
The pattern of gene expression in mouse Gr-1(+) myeloid progenitor cells. (2001) (8)
Generation of longer cDNA fragments from SAGE tags for gene identification. (2003) (8)
The impact of new DNA diagnostic technology on the management of cancer patients. Survey of diagnostic techniques. (1993) (8)
Assignment of the human GDID4 gene, a GDP/GTP-exchange regulator, to chromosome 12p12.3. (1994) (7)
Molecular analysis of a t(11;14)(q23;q11) from a patient with null‐cell acute lymphoblastic leukemia (1993) (7)
Genes and Cancer (1985) (7)
ISCN (2005) is not acceptable for describing clonal evolution in cancer (2007) (7)
Chromosome changes in hematologic malignancies (1981) (7)
Genes, chromosomes & cancer: A new forum for research in cancer genetics (1989) (7)
Cytogenetic and molecular analysis of pediatric neoplasms: diagnostic and clinical implications. (1994) (7)
Molecular analysis of the t(8;14)(q24;q11) chromosomal breakpoint junctions in the T-cell leukemia line MOLT-16. (1997) (7)
The chimeric genes AMLl /MDS1 and AML1 /EAP inhibit AML1B activation at the CSF1R promoter, but only AMLl /MDS1 has tumor-promoter properties (2005) (7)
The proportion of abnormal karyotypes in acute leukemia samples related to method of preparation. (1991) (7)
Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies. (1997) (7)
TEL and KIP 1 Define the Smallest Region of Deletions on 1 2 ~ 1 3 in Hematopoietic Malignancies (2000) (7)
Constitutional t(15;17): clarification of the chromosomal breakpoints. (1986) (6)
Leukemias, Lymphomas, and Other Related Disorders (2013) (6)
A balanced translocation (17;22) and a pericentric inversion of chromosome 5. Repository identification No. GM3196. (1980) (6)
Consistent chromosomal rearrangements in human malignant disease and oncogene location (1984) (6)
Transcription and hybridization of 125I-cRNA from flow sorted chromosomes (1979) (6)
Hypercalcemia and lytic bone lesions in a patient with B-cell non-Hodgkin's lymphoma. (1984) (6)
Banding studies on chromosomes in diffuse "histiocytic" lymphomas: correlation of 14q+ marker chromosome with cytology. (1978) (6)
Chromosomal and growth factor abnormalities in leukemia. AACR special conference in cancer research. (1991) (5)
Culture conditions in chronic lymphocytic leukemia: relationship to karyotype. (1989) (5)
Chromosome translocations: good genes gone wrong. (1995) (5)
Significance of Chromosome Rearrangements in Leukemia and Lymphoma (1985) (5)
Cytogenetic and molecular study of the PRDX4 gene in a t(X;18)(p22;q23): a cautionary tale. (2007) (5)
Targeting mutations predictably. (2011) (5)
Recurring Chromosome Rearrangements in Human Cancer (2003) (5)
Detection of 9p deletions in leukemia cell lines by interphase fluorescence in situ hybridization with YAC-derived probes. (1995) (5)
Oncogenes and retroviruses. Evaluation of basic findings and clinical potential (1984) (4)
Chromosomal localization of the human T cell receptor beta-chain genes. (1985) (4)
Analysis of tumor suppressor gene on human chromosome 9 in mouse x human somatic cell hybrids (1994) (4)
Cytogenetic analysis of 51 patients with chronic myeloid leukemia. (1990) (4)
1993 Robert R. deVilliers Lecture. Chromosome translocations: dangerous liaisons. (1994) (4)
Nonrandom involvement of chromosomal segments in human hematologic malignancies (1977) (4)
Cloning of the breakpoint junction of the translocation 14;19 in chronic lymphocytic leukemia. (1989) (4)
Identification of pericentric inversion 12, inv(12)(p13.1q11), by fluorescence in situ hybridization in a patient with acute myeloid leukemia (AML-M6). (1997) (3)
T-immunophenotype is associated with an increased prevalence of thrombosis in children with acute lymphoblastic leukemia. A retrospective study (2003) (3)
An improved technique for sequential R-, Q- and C-banding of bone marrow chromosomes. (1983) (3)
The use of methylthioadenosine phosphorylase activity to select for human chromosome 9 in interspecies and intraspecies hybrid cells (1993) (3)
Chromosome Abnormalities and Oncogenes in Human Leukemia and Lymphoma (1987) (3)
Leukemia with inv ( 16 )-SMMHC in Acute Myelogenous β ( p 15 ) by CBF INK 4 b Methylation-Independent Silencing of the Tumor Suppressor (2007) (3)
Fourth International Workshop on Chromosomes in Leukemia 1982: Chromosomes in acute promyelocytic leukemia. (1984) (3)
Chromosome abnormalities in human leukemia as indicators of mutagenic exposure. (1985) (3)
A Burkitt-lymphoma variant translocation (2p-; 8q+) in a patient with ALL, L3 (Burkitt type) (2004) (3)
Chromosome studies in children and adults with leukemia. (1981) (3)
Evaluation of techniques for increasing mitotic yield and chromosome length in leukemic cells. (1984) (3)
Chromosome abnormalities in human acute nonlymphocytic leukemia: relationship to age, sex, and exposure to mutagens. (1982) (3)
Chromosomes and cancer (1982) (2)
The Outer Circle: Women in the Scientific Community Edited by Harriet Zuckerman, Jonathan R. Cole, and John T. Bruer (review) (2015) (2)
Molecular analysis of rearrangements in Philadelphia (Ph1) chromosome-positive leukemia. (1989) (2)
Cancer advisory board. (1982) (2)
A review of recent studies of chromosomes in mongolism. (1962) (2)
Social media marketing strategy in English football clubs (2022) (2)
The implications of nonrandom chromosome changes for malignant transformation. (1981) (2)
Chromosomal DNA cytophotometry in 20q- nonspecific myeloid disorders. (1979) (2)
Genes and cancer : proceedings of a CETUS-UCLA Symposium held in Steamboat Springs, Colorado, March 11-17, 1984 (1984) (2)
The relationship of chromosomal abnormalities to neoplasia. (1976) (2)
The clinical usefulness of chromosome studies in patients with leukemia. (1980) (2)
The use of bone core biopsies for cytogenetic analysis (1979) (2)
Clinical Significance of Chromosome Abnormalities in Childhood and Adult Leukemia (1982) (2)
Prognostic significance of posttransfusion hepatitis and chromosomal abnormalities in adult acute nonlymphocytic leukemia. (1982) (2)
Molecular Cytogenetics: Rosetta Stone for Understanding Cancerâ€”Twenty-ninth Lecture1 (2006) (1)
Chromosome Translocations Play a Key Role in Leukemogenesis (1997) (1)
Multiple cytogenetically abnormal clones in two polycythemia vera patients (2004) (1)
Acute Myeloid Leukemia and Myelodysplastic Syndrome Associated with Prior Cytotoxic Therapy (2003) (1)
Screening poly [dA/dT(-)] cDNA for gene identification. (2003) (1)
Theodore T. Puck (September 24, 1916–November 6, 2005) (2006) (1)
2002 William Allen Award address. Introductory speech for Albert de la Chapelle. (2003) (1)
CHROMOSOMES IN THE MYELODYSPLASIAS. (1968) (1)
Cancer Genomics: The Road Ahead (2013) (1)
Introductory Speech for Albert de la Chapelle * * Previously presented at the annual meeting of The (2003) (1)
Screening poly ( dA y dT ) 2 cDNAs for gene identification (2000) (1)
Cancer Cytogenetics 2d ed., Sverre Heim, Felix Mitelman, in: xx. Wiley-Liss, New York (1995), Pp. 536. $59.95 (1997) (1)
Evolution of Karyotypes in Acute Nonlymphocytic Leukemia 1 (2006) (1)
From clonal theory to malignancy Chromosome mutation and neoplasia. Edited by J. German. New York: Alan R. Liss, Inc. (1983). 486 pp. $96.00 (1984) (1)
MEL1 at 1p36.3 Is Fused to Several Partner Genes Including HOXA9 Located at Different Chromosomal Bands from 3q21.3 in t(1;3)(p36.3;q21.3)-Leukemia. (2007) (1)
Catalog of chromosome aberrations in cancers, 2nd ed. Felix Mitelman. New York: Alan R. Liss, Inc., 1985, 707 pp, $96 (1987) (1)
Prognostic significance of the AML1-ETO fusion transcript expression in children and young adults with t(8;21) acute myeloid leukemia. (2003) (1)
Response to letter by the ISCN standing committee (2007) (1)
Blockade of Mir-150 Maturation by MLL-Fusion/MYC/Lin-28 Is Required for MLL-Associated Leukemia (2012) (1)
MULTIPLE CHROMOSOME ABERRATIONS IN DOWN'S SYNDROME ASSOCIATED WITH TWINNING AND ACUTE GRANULOCYTIC LEUKÆMIA (1964) (1)
MLL-Rearrangements Result in Upregulation of Mir-9 and Subsequent Inhibition of the Tumor Suppressor TGFBI (2011) (1)
Finding Order in Chaos (2015) (0)
Re: G. Cimino et al., Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res., 51: 6712-6714, 1991. (1992) (0)
Introduction to the cellular and molecular biology of cancer Edited by L. M. Franks and N. Teich. Oxford: Oxford University Press. (1986). 458 pp. $49.95 (1987) (0)
Cytogenetic analysis of bone marrow and peripheral blood samples stored in fixative for several years. (1981) (0)
Abstract 2309: Down-regulation of miR-181b contributes to the poor prognosis of adverse cytogenetically abnormal acute myeloid leukemia by targeting PBX3 (2012) (0)
MicroRNA Expression Profiles in Acute Myeloid Leukemia with Common Translocations. (2007) (0)
Advances in Brief Assignment of the Human p 27 Kipl Gene to 12 pl 3 and Its Analysis in Leukemias 1 (2006) (0)
Correlation of chromosome patterns in human leukemic cells with exposure to chemicals and/or radiation. Progress report, July 1992--August 1993 (1993) (0)
Correlation of chromosome patterns in human leukemic cells with exposure to chemicals and/or radiation. Final report, January 1--December 31, 1997 (1998) (0)
Clinical aspects of chromosome studies (1969) (0)
Molecular studies of translocation 6 9 in acute leukemia role of c abl (1986) (0)
16 defines the critical fusion for leukemogenesis Molecular characterization of 16p deletions associated with inversion (2011) (0)
Activation of a Mir-181-Targeting HOXA-PBX3 Homeobox Gene Signature Is Associated with Adverse Prognosis of Cytogenetically Abnormal Acute Myeloid Leukemia (2011) (0)
intheU937celllineresults inthefusion oftheAFJOgeneandCALM,encoding anewmemberofthe AP-3clathrin assembly protein family (1996) (0)
Jake, Leon O. Jacobson, M.D.: The Life and Work of a Distinguished Medical Scientist (review) (2007) (0)
Identification of a Novel Alternatively Spliced Form of AML1-ETO and Analysis of Its Role in Leukemogenesis. (2004) (0)
Gene Expression Profiles in Acute Myeloid Leukemias (AML): A Novel Approach Using SAGE and Custom Microarray. (2004) (0)
Phenotypic changes and alterations of target gene expression in the 32D murine myeloid cell line infected with various AML1 fusion genes (1997) (0)
Abstract 1821: MiR-9 is an oncogenic microRNA specifically overexpressed in MLL-rearrangement leukemia. (2013) (0)
MLL-Rearranged Acute Myeloid Leukemias Drive Expression Of Mir-9, a Critical Oncogene In Leukemogenesis (2013) (0)
Correlation of chromosome patterns in human leukemic cells with exposure to chemicals and/or radiation. Comprehensive progress report, July 1991--June 1992 (1992) (0)
Undetected chromosome abnormalities in leukemia: a cautionary note. (1981) (0)
Genome-wide analysis of gene expression in myeloid progenitor cells (2001) (0)
The decade performance assessment program (2012) (0)
Thyroid Cancer : A Storied Past and Promising Future (2014) (0)
DYSMORPHIC SYNDROME, SPHEROCYTOSIS AND PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 8 (1984) (0)
Everything (and more) that you need to know about chromosome abnormalities in neoplasia (1992) (0)
Methylation-Independent Silencing of the Tumor Suppressor p15INK4B by CBFb-SMMHC in Acute Myeloid Leukemias with inv(16). (2005) (0)
Identification of Genes Abnormally Expressed in Human MLL-AF4 Leukemia. (2006) (0)
Medicine in the Focal Spot of the Natural Sciences, Technology, and Humanity (2015) (0)
Correlation of chromosome patterns in human leukemic cells with exposure to chemicals and/or radiation (1992) (0)
Recurring genetic aberrations in cancer cells: chromosomes as potential targets for nuclear medicine imaging. (1995) (0)
Translocations With TEL and CDKN 2 Inactivation in Acute Lymphoblastic Leukemia Cell Lines (2002) (0)
Introduction to special issue for Alfred G. Knudson (2003) (0)
H'-THYMIDINE UPTAKE BY A RING X CHROMOSOME IN A HUMAN FEMALE BY JANET ROWLEY, SYLFEST MULDAL, (0)
Co-creation of place brands? (2021) (0)
Absence of the 9q plus chromosome in Ph1 negative chronic myelogenous leukaemia. (1974) (0)
Editorial help (2004) (0)
MLL-Associated Leukemias Drive Expression of MiR-9, Required for Tumorigenesis (2012) (0)
Leukemias: Association With Prior Therapy Translocations With Novel Partner Chromosomes in Myeloid (2011) (0)
The Location of Genomic Breakpoints in AML1/RUNX1 and ETO in De Novo znd Therapy-Related Leukemia Patients sith T(8;21) Are Similar znd Colocalize with Topoisomerase II Cleavage Sites. (2004) (0)
Human T-Cell Lymphoma With Suppressor Effects on the Mixed Lymphocyte Reaction ( MLR ) (2005) (0)
Erratum (Retracted article): (November 18, 2002) 196, 10, (1291-1305) (2006) (0)
Planning the Genome Institute's future [1] (multiple letters) (2003) (0)
Preface (2002) (0)
Identification of Genes Abnormally Expressed in Both Human and Murine MLL-ELL and/or MLL-ENL Leukemia. (2006) (0)
Introduction to the editors (1978) (0)
Cancer Cytogenetics. 2d ed.By Sverre Heim and Felix Mitelman (1997) (0)
BiologicalImplications of ConsistentChromosome Rearrangements in Leukemiaand Lymphoma1 (1984) (0)
Quantificationby DNA-basedCytophotometryof the 9q+/22qâ€" ChromosomalTranslocationAssociatedwith Chronic MyelogenousLeukemia1 (1977) (0)
DNA Diagnosis in Oncology (1994) (0)
Have skills, will travel. (2012) (0)
The effect of refrigeration of bone marrow and peripheral blood on cytogenetic analysis (1986) (0)
A Critical Role of Mir-9 in Myelopoesis and EVI1-Induced Leukemogenesis. (2012) (0)
Editorial (1990) (0)
Molecular Diagnosis and Monitoring in Aml with Inversion 16 (inv16) (1993) (0)
Rare recurring chromosomal abnormalities. Report of an international workshop on the relationship of prior therapy to balanced chromosome rearrangements in treatment-related leukemia and myelodysplasia (2000) (0)
The HOXA/PBX3 Pathway Is an Attractive Therapeutic Target in MLL-Rearranged Acute Leukemia (2012) (0)
Correlation of chromosome patterns in human leukemic cells with exposure to chemicals and/or radiation. Progress report, January 1, 1980-Dec 31, 1980. [Consequences of radiotherapy and/or chemotherapy] (1980) (0)
AML1 and Pebp2: the gene for a transcription factor is involved in recurring translocations in human acute myeloid leukemia. (1994) (0)
Chromosomal translocations in human malignant diseases (1993) (0)
Identification of the Genomic Breakpoints at 1p36.3 and 3q21.3 in Five MDS/AML(M4) Patients with t(1;3)(p36;q21) Translocation. GATA2 Mutation May Be Involved in Leukemogenesis. (2004) (0)
Marketing strategy and planning (2017) (0)
Genes Similarly Abnormally Expressed in Both Human and Murine MLL-Associated Leukemia. (2005) (0)
Gene Expression Profiles in Acute Myeloid Leukemia (AML): From Diagnosis to Prognosis. (2005) (0)
Cytogenetic and molecular study of the PRDX4 gene in a translocation (X;18)(p22;q23) – a cautionary tale (2007) (0)
BiologicalImplicationsof ConsistentChromosomeRearrangementsin Leukemiaand Lymphoma1 (2006) (0)
Cancer advisory board. (1982) (0)
Cytogenetic and molecular study of the PRDX4 gene in a t(X; 18)(p22; q23) translocation. (2005) (0)
How And Why Recurring Chromosomal Abnormalities Occur (2003) (0)
Assignment of the Human p27Kipl Gene to 12pl3 and Its Analysis in Leukemias1 (1995) (0)
Breakpoint Cluster Region MLL Site Colocalize Near Exon 9 in the An In Vivo Topoisomerase II Cleavage Site and a DNase I Hypersensitive (2010) (0)
Identification of Genes Deregulated in Both Human and Murine MLLRearrangement Leukemias. (2008) (0)
Sister Chromatid Exchange, Avery A. Sandberg (Ed.), in: Progress and Topics in Cytogenetics Series, vol 2. Alan R. Liss, New York (1982) (1982) (0)
Molecular cytogenetic characterization of breakpoints in 19 patients with hematologic malignancies and 12 p unbalanced translocations (2003) (0)
Mll Involvement In Treatment Related Aml and Mds (1997) (0)
Catalog of chromosome aberrations in cancer: by Felix Mitelman. Third edition, 1,146 pp., 1988, New York, Alan R. Liss, Inc. (1989) (0)
Correlation of chromosome patterns in human leukemic cells with exposure to chemicals and/or radiation. Comprehensive progress report, July 1991--June 1994 (1994) (0)
Nonrandom Chromosome Abnormalities in Angioimmunoblastic (1982) (0)
ChromosomeAbnormalities in Poorly Differentiated Lymphocytic Lymphoma1 (1979) (0)
The Model: Palle Nielsen (2015) (0)
Repression of Mir-495, a Microrna Associated with Favorable Outcome of Acute Myeloid Leukemia Patients, Is Required for the MLL -Associated Leukemogenesis, (2011) (0)

This paper list is powered by the following services:

Other Resources About Janet Rowley

en.wikipedia.org

What Schools Are Affiliated With Janet Rowley?

Janet Rowley is affiliated with the following schools:

Image Attributions

Image Source for Janet Rowley